Evidence map›Paper›PMID 27028278›Full record

ArticleObesity (Silver Spring, Md.)2016

Placebo effects in obesity research.

Kevin R Fontaine, Michelle S Williams, Teri W Hoenemeyer, Ted J Kaptchuk, Gareth R Dutton

Abstract readEditorial
In one paragraph

Article in Obesity (Silver Spring, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Review
  11. Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis.Liver international : official journal of the International Association for the Study of the Liver · 2021
    Review
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kevin R FontaineDepartment of Health Behavior, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Michelle S WilliamsDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Teri W HoenemeyerComprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Ted J KaptchukProgram of Placebo Studies and the Therapeutic Encounter, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Gareth R DuttonDivision of Preventive Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Stuart J Frank · 2013 to 2026
$19.5M
UAB Health Services Research (HSR) Training ProgramT32HS013852 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVITAN, EMILY B, MUGAVERO, MICHAEL J · 2003 to 2024
$8.0M
Mentoring and Research in Placebo Studies, Asian Medicine, and CAMK24AT004095 · NCCIH · HARVARD MEDICAL SCHOOL · PI KAPTCHUK, TED · 2007 to 2016
$1.4M
Improving Weight Loss Maintenance through Alternative Schedules of TreatmentK23DK081607 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DUTTON, GARETH R · 2010 to 2014
$849k
AHRQ HHS T32 HS013852NCCIH NIH HHS K24 AT004095NIDDK NIH HHS K23 DK081607NIDDK NIH HHS P30 DK079626
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID27028278
PMCPMC4817362

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.